PURPOSE: To investigate the relationship between jaw function, patient and treatment variables, and radiation dosimetry of the mandibular muscles and joints in children and young adults receiving radiation for soft-tissue and bone sarcomas. METHODS AND MATERIALS: Twenty-four pediatric and young adult patients with head-and-neck sarcomas were treated on an institutional review board-approved prospective study of focal radiation therapy for local tumor control. Serial jaw depression measurements were related to radiation dosimetry delivered to the medial and lateral pterygoid muscles, masseter muscles, and temporomandibular joints to generate mathematical models of jaw function. RESULTS: Baseline jaw depression was only influenced by the degree of surgical resection. In the first 12 weeks from initiation of radiation, surgical procedures greater than a biopsy, administration of cyclophosphamide containing chemotherapy regimes, and large gross tumor volumes adversely affected jaw depression. Increasing dose to the pterygoid and masseter muscles above 40 Gy predicted loss of jaw function over the full course of follow-up. CONCLUSIONS: Clinical and treatment factors are related to initial and subsequent jaw dysfunction. Understanding these complex interactions and the affect of specific radiation doses may help reduce the risk for jaw dysfunction in future children and young adults undergoing radiation therapy for the management of soft-tissue and bone sarcomas.
PURPOSE: To investigate the relationship between jaw function, patient and treatment variables, and radiation dosimetry of the mandibular muscles and joints in children and young adults receiving radiation for soft-tissue and bone sarcomas. METHODS AND MATERIALS: Twenty-four pediatric and young adult patients with head-and-neck sarcomas were treated on an institutional review board-approved prospective study of focal radiation therapy for local tumor control. Serial jaw depression measurements were related to radiation dosimetry delivered to the medial and lateral pterygoid muscles, masseter muscles, and temporomandibular joints to generate mathematical models of jaw function. RESULTS: Baseline jaw depression was only influenced by the degree of surgical resection. In the first 12 weeks from initiation of radiation, surgical procedures greater than a biopsy, administration of cyclophosphamide containing chemotherapy regimes, and large gross tumor volumes adversely affected jaw depression. Increasing dose to the pterygoid and masseter muscles above 40 Gy predicted loss of jaw function over the full course of follow-up. CONCLUSIONS: Clinical and treatment factors are related to initial and subsequent jaw dysfunction. Understanding these complex interactions and the affect of specific radiation doses may help reduce the risk for jaw dysfunction in future children and young adults undergoing radiation therapy for the management of soft-tissue and bone sarcomas.
Authors: Matthew J Krasin; Xiaoping Xiong; Wilburn E Reddick; Robert J Ogg; Fredric A Hoffer; Beth McCarville; Sue C Kaste; Sheri L Spunt; Fariba Navid; Andrew M Davidoff; Lingqing Zhang; Larry E Kun; Thomas E Merchant Journal: Magn Reson Imaging Date: 2006-10-25 Impact factor: 2.546
Authors: Holcombe E Grier; Mark D Krailo; Nancy J Tarbell; Michael P Link; Christopher J H Fryer; Douglas J Pritchard; Mark C Gebhardt; Paul S Dickman; Elizabeth J Perlman; Paul A Meyers; Sarah S Donaldson; Sheila Moore; Aaron R Rausen; Teresa J Vietti; James S Miser Journal: N Engl J Med Date: 2003-02-20 Impact factor: 91.245
Authors: Chiaho Hua; Jonathan M Gray; Thomas E Merchant; Larry E Kun; Matthew J Krasin Journal: Int J Radiat Oncol Biol Phys Date: 2008-01-30 Impact factor: 7.038
Authors: David N Teguh; Peter C Levendag; Peter Voet; Henri van der Est; Inge Noever; Willy de Kruijf; Peter van Rooij; Paul I M Schmitz; Ben J Heijmen Journal: Head Neck Date: 2008-05 Impact factor: 3.147
Authors: Ann C Mertens; Yutaka Yasui; Yan Liu; Marilyn Stovall; Ray Hutchinson; Jill Ginsberg; Charles Sklar; Leslie L Robison Journal: Cancer Date: 2002-12-01 Impact factor: 6.921
Authors: Andrew Wentzel; Peter Hanula; Lisanne V van Dijk; Baher Elgohari; Abdallah S R Mohamed; Carlos E Cardenas; Clifton D Fuller; David M Vock; Guadalupe Canahuate; G E Marai Journal: Radiother Oncol Date: 2020-05-16 Impact factor: 6.280
Authors: Aimee C Talleur; Fariba Navid; Sheri L Spunt; M Beth McCarville; John Wu; Shenghua Mao; Andrew M Davidoff; Michael D Neel; Matthew J Krasin Journal: Int J Radiat Oncol Biol Phys Date: 2016-04-12 Impact factor: 7.038
Authors: John T Lucas; Israel Fernandez-Pineda; Christopher L Tinkle; Michael W Bishop; Sue C Kaste; Rajiv Heda; Andrew M Davidoff; Matthew J Krasin Journal: Pract Radiat Oncol Date: 2017-04-26